Sacroiliitis in Systemic Lupus Erythematosus Revisited

This study aims to investigate the prevalence of inflammatory back pain (IBP) and sacroiliitis in a systemic lupus erythematosus (SLE) population as well as the association between IBP and the frequency of human leukocyte antigen B27 (HLA-B27). The study included 281 SLE patients (16 males, 265 fema...

Full description

Saved in:
Bibliographic Details
Published inArchives of rheumatology Vol. 35; no. 2; pp. 254 - 258
Main Authors Yilmaz, Neslihan, Yazici, Ayten, Özulu TÜrkmen, Banu, Karalok, Işık, Yavuz, Şule
Format Journal Article
LanguageEnglish
Published Turkey Turkish League Against Rheumatism 01.06.2020
Prof Sebnem Ataman, President Turkish League Against Rheumatism
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This study aims to investigate the prevalence of inflammatory back pain (IBP) and sacroiliitis in a systemic lupus erythematosus (SLE) population as well as the association between IBP and the frequency of human leukocyte antigen B27 (HLA-B27). The study included 281 SLE patients (16 males, 265 females; mean age 39.9±11.9 years; range, 20 to 69 years) and 100 healthy controls (HCs) (2 males, 98 females; mean age 41.2±10.1 years; range, 19 to 64 years). Participants were administered a five-item Assessment of SpondyloArthritis international Society-IBP questionnaire. Patients and controls with IBP underwent detailed clinical and laboratory examinations to detect sacroiliitis. Radiographic evaluations were performed by a blinded rheumatologist and radiologist. Interobserver reliability was assessed with Cohen's kappa test. According to the questionnaire, IBP was present in 46 SLE patients (46/281; 16.3%) whereas none of the HC had IBP (p<0.001). In radiological assessment, 22 SLE patients (7.8%) had sacroiliitis detected by conventional X-ray and/or magnetic resonance imaging. Only one SLE patient with sacroiliitis had HLA-B27. Our study showed that IBP is increased in SLE patients and IBP in SLE is not associated with HLA-B27.
ISSN:2148-5046
1309-0291
2618-6500
1309-0283
DOI:10.46497/ArchRheumatol.2020.7514